Development of a microfluidic cell transfection device into gene-edited CAR T cell manufacturing workflow

We developed a workflow to produce potent gene-edited CAR T cells that combines microfluidic transfection and lentiviral transduction using healthy donor- and patient-derived T cells. We developed an understanding on how biomechanics of cells impact mechanoporation.